Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
CubeX to host conference on consumer healthcare in Mumbai
It would cover diverse topics such as building mega brands to penetrating unchartered territories, creating multiple touch points…
IPM clocks Rs 10,278 cr in Sept 2016
Domestic companies continued to dominate the market with a 79 per cent share
Uniquity India focuses on bridging the gaps in global serialisation mandates
With the DSCSA and other serialisation deadlines looming ahead, Uniquity India 2016 served as a timely status check By Viveka…
In search of sustainable growth
When Ministers speak like CEOs, industry sits up and listens. The relatively newly minted state of Telangana is racing to catch up…
Express Pharma (Vol.12, No.1) November 1-15, 2016
India's Foremost Pharma & Biotech Magazine
Strides, Mylan agree to settle claims on Agila sale
Strides will receive approximately $30 million
EMA accepts for review Mylan and Biocon’s Regulatory Submission for Insulin Glargine
It includes analytical, functional and pre-clinical data, as well as results from PK and confirmatory efficacy/safety global…
GreenSignal Bio Pharma fixes price band of Rs 76-80 for IPO
The company plans to raise Rs 112 crore
Vaccine manufacturing firm GreenSignal Bio Pharma has fixed the price band at Rs 76-80…
Vyome Biosciences administers first in-human dose of VB 1953 in US
The Phase 1 clinical study was conducted in patients with facial acne
Ajanta Pharma launches BP lowering tablets in US
The company’s product is a generic version of Daiichi Sankyo's Azor tablets